Jnana Therapeutics Is A Clinical Stage Biotechnology Company Based In Bostonfocused On Small Molecule Drug Discoveryutilizing Its Proprietary Rapid Chemoproteomics Platformjnana Aims To Address Significant Medical Needs By Targeting Challenging Proteins Involved In Various Diseasesincluding Rare Genetic Disorders And Immune Mediated Conditionsthe Company Was Acquired By Otsuka Pharmaceutical In September 2024Which Enhances Its Ability To Develop Therapies Through Clinical Stages The Rapid Platform Enables The Identification Of Unique Binding Sites On Protein Targetsfacilitating The Discovery Of Small Molecule Therapiesthis Innovative Approach Allows Jnana To Tackle Targets That Have Traditionally Been Difficult To Drugthe Company Is Advancing Its Pipeline With Jnt 517An Oral Therapy For Phenylketonuriapku And Is Developing Preclinical Candidates For Immune Mediated Diseasesjnana Collaborates With Notable Investors And Pharmaceutical Partnerspositioning Itself Strongly Within The Biotechnology Landscape
No conferences found for this company.
| Company Name | Jnana Therapeutics |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
